About Freenome Health
Freenome Health is a company based in United States founded in 2014.. Freenome Health has raised $1.35 billion across 8 funding rounds from investors including Fidelity Investments, Verily and Kaiser Permanente. The company has 533 employees as of December 31, 2023. Freenome Health has completed 1 acquisition, including Oncimmune. Freenome Health offers products and services including Intelligent Screening Platform and Early Cancer Detection Tests. Freenome Health operates in a competitive market with competitors including Miroculus, Geneoscopy, UDX, InterVenn and HalioDx, among others.
- Headquarter United States
- Employees 533 as on 31 Dec, 2023
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Freenome Holdings, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.35 B (USD)
in 8 rounds
-
Latest Funding Round
$254 M (USD), Series E
Feb 15, 2024
-
Investors
Fidelity Investments
& 54 more
-
Employee Count
533
as on Dec 31, 2023
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Freenome Health
Freenome Health offers a comprehensive portfolio of products and services, including Intelligent Screening Platform and Early Cancer Detection Tests. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Uses AI and multiomics for early cancer detection via blood draws.
Develops and validates tests for treatable cancer stages.
Unlock access to complete
Unlock access to complete
Product Management Team
33 people
Software Development Team
24 people
Leadership Team
18 people
Senior Team
9 people
Human Resources and Administration
5 people
Staff Team
4 people
Data Analysis and Operations Team
4 people
Research Team
2 people
Unlock access to complete
Funding Insights of Freenome Health
Freenome Health has successfully raised a total of $1.35B across 8 strategic funding rounds. The most recent funding activity was a Series E round of $254 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series E — $254.0M
-
First Round
First Round
(08 Jan 2014)
- Investors Count 55
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Series E - Freenome Health | Valuation | Roche | |
| Jan, 2022 | Amount | Series D - Freenome Health | Valuation | Roche | |
| Nov, 2021 | Amount | Series D - Freenome Health | Valuation | Perceptive Advisors , RA Capital Management |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Freenome Health
Freenome Health has secured backing from 55 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Fidelity Investments, Verily and Kaiser Permanente. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
BrightEdge is focused on impact investment in cancer care innovation.
|
Founded Year | Domain | Location | |
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in the healthcare sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Freenome Health
Freenome Health has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Oncimmune. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diagnostics and risk assessment solutions for lung cancer are developed.
|
2006 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Freenome Health
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Freenome Health Comparisons
Competitors of Freenome Health
Freenome Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Miroculus, Geneoscopy, UDX, InterVenn and HalioDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
MicroRNA profiling platform is developed to detect genes in samples.
|
|
| domain | founded_year | HQ Location |
Non-invasive biomarker tests for colorectal cancer are developed.
|
|
| domain | founded_year | HQ Location |
Non-invasive blood-based diagnostics for early cancer detection are developed.
|
|
| domain | founded_year | HQ Location |
Provider of an AI-based clinical decision supporting tool for cancer detection and drug development
|
|
| domain | founded_year | HQ Location |
Developer of diagnostic product for colon cancer
|
|
| domain | founded_year | HQ Location |
Digital women's health management software for employers and individuals
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Freenome Health
Frequently Asked Questions about Freenome Health
When was Freenome Health founded?
Freenome Health was founded in 2014.
Where is Freenome Health located?
Freenome Health is headquartered in United States.
Is Freenome Health a funded company?
Freenome Health is a funded company, having raised a total of $1.35B across 8 funding rounds to date. The company's 1st funding round was a Series D of $300M, raised on Jan 08, 2014.
How many employees does Freenome Health have?
As of Dec 31, 2023, the latest employee count at Freenome Health is 533.
What does Freenome Health do?
Freenome Health was founded in 2014 in the United States. A deep learning platform is offered for identifying circulating cancer-related markers in patient blood samples. Proprietary technology is utilized to detect cell-free DNA, immune cell fragments, and metabolic markers. Tumor types are classified through the platform, and treatment therapies for prostate, breast, colorectal, and lung cancers are supported in the health technology sector.
Who are the top competitors of Freenome Health?
Freenome Health's top competitors include Geneoscopy, UDX and InterVenn.
What products or services does Freenome Health offer?
Freenome Health offers Intelligent Screening Platform and Early Cancer Detection Tests.
How many acquisitions has Freenome Health made?
Freenome Health has made 1 acquisition, including Oncimmune.
Who are Freenome Health's investors?
Freenome Health has 55 investors. Key investors include Fidelity Investments, Verily, Kaiser Permanente, Intermountain Healthcare, and Roche.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.